UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Neurogenic Dural Protein Extravasation Induced by Meta-Chlorophenylpiperazine (Mcpp) Involves Nitric Oxide and 5-HT2B Receptor Activation

Cephalalgia, 2003-03, Vol.23 (2), p.117-123

2003

Volltextzugriff (PDF)

Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors

Naunyn-Schmiedeberg's archives of pharmacology, 1999-01, Vol.359 (1), p.1-6

1999

Volltextzugriff (PDF)

Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus

Molecular pharmacology, 1992-10, Vol.42 (4), p.549-557

1992

Volltextzugriff (PDF)

Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor

Molecular pharmacology, 1993-03, Vol.43 (3), p.419-426

1993

Volltextzugriff (PDF)

Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines

The Journal of pharmacology and experimental therapeutics, 1993-06, Vol.265 (3), p.1272

1993

Volltextzugriff (PDF)

Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor

Molecular pharmacology, 1994-08, Vol.46 (2), p.227-234

1994

Volltextzugriff (PDF)

Substituted Naphthofurans as Hallucinogenic Phenethylamine−Ergoline Hybrid Molecules with Unexpected Muscarinic Antagonist Activity

Journal of medicinal chemistry, 1998-06, Vol.41 (12), p.2134-2145

1998

Volltextzugriff (PDF)

Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences

The Journal of pharmacology and experimental therapeutics, 1996-02, Vol.276 (2), p.720

1996

Volltextzugriff (PDF)

Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups

Journal of medicinal chemistry, 1996-07, Vol.39 (15), p.2953-2961

1996

Volltextzugriff (PDF)

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine

The Journal of pharmacology and experimental therapeutics, 2000-08, Vol.294 (2), p.688

2000

Volltextzugriff (PDF)

Dihydrobenzofuran Analogues of Hallucinogens. 4. Mescaline Derivatives

Journal of medicinal chemistry, 1997-09, Vol.40 (19), p.2997-3008

1997

Volltextzugriff (PDF)

DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities

The Journal of pharmacology and experimental therapeutics, 1993-08, Vol.266 (2), p.943

1993

Volltextzugriff (PDF)

Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily

Life sciences (1973), 1996-08, Vol.59 (13), p.1081-1095

1996

Volltextzugriff (PDF)

Mutations of transmembrane IV and V serines indicate that all tryptamines do not bind to the rat 5-HT2A receptor in the same manner

Brain research. Molecular brain research., 1997-10, Vol.49 (1-2), p.1-6

1997

Volltextzugriff (PDF)

Human 5-HT1F receptor-stimulated [35S]GTPγS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

European journal of pharmacology, 1998-07, Vol.352 (1), p.117-124

1998

Volltextzugriff (PDF)

A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines

Life sciences (1973), 1996-09, Vol.59 (15), p.1259-1268

1996

Volltextzugriff (PDF)

Advances toward new antidepressants beyond SSRIS: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4

Bioorganic & medicinal chemistry letters, 2004-05, Vol.14 (10), p.2653-2656

2004

Volltextzugriff (PDF)

Molecular Biology of Serotonin Receptors

Obesity research, 1995-11, Vol.3 (S4), p.441S-447S

1995

Volltextzugriff (PDF)

Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1

Bioorganic & medicinal chemistry letters, 2003-06, Vol.13 (11), p.1903-1905

2003

Volltextzugriff (PDF)

Novel Potent 5-HT1F Receptor Agonists: Structure−Activity Studies of a Series of Substituted N-[3-(1-Methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides

Journal of medicinal chemistry, 2003-07, Vol.46 (14), p.3060-3071

2003

Volltextzugriff (PDF)

Advances toward new antidepressants beyond SSRIS: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3

Bioorganic & medicinal chemistry letters, 2003-11, Vol.13 (22), p.3939-3942

2003

Volltextzugriff (PDF)

Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists

Bioorganic & medicinal chemistry letters, 2004-12, Vol.14 (24), p.6011-6016

2004

Volltextzugriff (PDF)

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties

Naunyn-Schmiedeberg's archives of pharmacology, 2005-03, Vol.371 (3), p.169-177

2005

Volltextzugriff (PDF)

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 2

Bioorganic & medicinal chemistry letters, 2003-07, Vol.13 (14), p.2393-2397

2003

Volltextzugriff (PDF)

Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT1F receptor agonists

Bioorganic & medicinal chemistry letters, 2004-01, Vol.14 (1), p.167-170

2004

Volltextzugriff (PDF)

1 – 25 von 57

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(54)
Mit Volltextzugriff
(46)

Publikationsform

Artikel
(56)
Reviews
(1)

Sprache

Englisch
(57)
Japanisch
(5)

Erscheinungsjahr

n.n

Thema

Science & Technology
(36)
Life Sciences & Biomedicine
(34)
Animals
(24)
Humans
(24)
Pharmacology & Pharmacy
(20)
Biological And Medical Sciences
(17)
Rats
(17)
Receptors, Serotonin - Metabolism
(15)
Medical Sciences
(14)
Male
(12)
Pharmacology. Drug Treatments
(12)
Chemistry, Medicinal
(11)
Neuropharmacology
(11)
Mice
(9)
Receptors, Serotonin - Drug Effects
(9)
Structure-Activity Relationship
(9)
Neurotransmitters. Neurotransmission. Receptors
(8)
Serotoninergic System
(7)
Brain - Metabolism
(6)
Chemistry
(6)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Neurogenic Dural Protein Extravasation Induced by Meta-Chlorophenylpiperazine (Mcpp) Involves Nitric Oxide and 5-HT2B Receptor Activation

Comparisons of hallucinogenic phenylisopropylamine binding affinities at cloned human 5-HT2A, 5-HT2B and 5-HT2C receptors

Molecular cloning, functional expression, and pharmacological characterization of a novel serotonin receptor (5-hydroxytryptamine2F) from rat stomach fundus

Pharmacological characteristics of the newly cloned rat 5-hydroxytryptamine2F receptor

Species differences in the pharmacology of the 5-hydroxytryptamine2 receptor: structurally specific differentiation by ergolines and tryptamines

Molecular cloning, functional expression, and mRNA tissue distribution of the human 5-hydroxytryptamine2B receptor

Substituted Naphthofurans as Hallucinogenic Phenethylamine−Ergoline Hybrid Molecules with Unexpected Muscarinic Antagonist Activity

Pharmacologic characterization of the human 5-hydroxytryptamine2B receptor: evidence for species differences

Dihydrobenzofuran Analogues of Hallucinogens. 3. Models of 4-Substituted (2,5-Dimethoxyphenyl)alkylamine Derivatives with Rigidified Methoxy Groups

The novel 5-Hydroxytryptamine(1A) antagonist LY426965: effects on nicotine withdrawal and interactions with fluoxetine

Dihydrobenzofuran Analogues of Hallucinogens. 4. Mescaline Derivatives

DOI and alpha-methylserotonin: comparative vascular and nonvascular smooth muscle effects and central 5-hydroxytryptamine2 receptor affinities

Receptor subtype and density determine the coupling repertoire of the 5-HT2 receptor subfamily

Mutations of transmembrane IV and V serines indicate that all tryptamines do not bind to the rat 5-HT2A receptor in the same manner

Human 5-HT1F receptor-stimulated [35S]GTPγS binding: correlation with inhibition of guinea pig dural plasma protein extravasation

A novel class of 5-HT2A receptor antagonists: aryl aminoguanidines

Advances toward new antidepressants beyond SSRIS: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 4

Molecular Biology of Serotonin Receptors

Advances toward new antidepressants beyond SSRIs: 1-Aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 1

Novel Potent 5-HT1F Receptor Agonists: Structure−Activity Studies of a Series of Substituted N-[3-(1-Methyl-4-piperidinyl)-1H-pyrrolo[3,2-b]pyridin-5-yl]amides

Advances toward new antidepressants beyond SSRIS: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 3

Design, synthesis and evaluation of bicyclic benzamides as novel 5-HT1F receptor agonists

[3H]LY334370, a novel radioligand for the 5-HT1F receptor. I. In vitro characterization of binding properties

Advances toward new antidepressants beyond SSRIs: 1-aryloxy-3-piperidinylpropan-2-ols with dual 5-HT1A receptor antagonism/SSRI activities. Part 2

Substituted furo[3,2-b]pyridines: novel bioisosteres of 5-HT1F receptor agonists

Suchergebnisse filtern